BACKGROUND: Neoadjuvant chemoradiotherapy followed by esophagogastrectomy has
become the standard of care for patients with locally advanced esophageal cancer. This …

BACKGROUND: Neoadjuvant chemoradiation followed by esophagectomy is currently the
standard of care for locally advanced esophageal cancer. This intense preoperative regimen …

Objective: We present and analyze long-term outcomes following multimodal therapy for
esophageal cancer, in particular the relative impact of histomorphologic tumor regression …

Purpose Attempts to improve survival of patients with esophageal cancer have been made
using induction chemoradiotherapy (CRT) followed by surgery. A large single-center …

Objectives The aim of this study was to evaluate differences in pathologic complete
response (pCR) rates and overall survival among patients receiving either neoadjuvant …

BACKGROUND: Neoadjuvant chemoradiation (CRT) is an accepted treatment for locally
advanced esophageal carcinoma. A survival benefit has not been definitively established …

AIM: To investigate the role of neoadjuvant chemoradiotherapy in prognosis and surgery for
esophageal carcinoma by a meta-analysis. METHODS: PubMed and manual searches were …

Objective: We sought to quantitatively and objectively evaluate histomorphologic tumor
regression and establish a relevant prognostic regression classification system for …

OBJECTIVE: We hypothesized that most relapses in patients with esophageal cancer having
neoadjuvant chemoradiation therapy would occur outside of the surgical and radiation …

Background The interval between neoadjuvant chemoradiation treatment and surgery has
been described as an important predictor of pathologic response to therapy in …